Deal by Cystic Fibrosis Foundation Raises Cash and Some Concern - NYTimes.com: "Proponents say it speeds drug development while also providing potential monetary rewards that can pay for even more research.
Continue reading the main story
But there is some concern that a profit motive could divert the organizations from their primary mission — helping patients — and create a conflict of interest. For instance, the price of the main drug developed through Cystic Fibrosis Foundation’s investment is $300,000 a year."
'via Blog this'
This blog contains assorted news and commentary on the fundraising profession and philanthropy gathered by the AFP Fundraising Resource Center. Other Sites of Interest Section Disclaimer: AFP provides the following listing of hyperlinks to other Internet pages as a privilege to the user. AFP does not necessarily endorse, support or attest to the accuracy of information posted on those Internet pages. Some links may require registration to view and/or may only be available for a limited time.
Thursday, November 20, 2014
Deal by Cystic Fibrosis Foundation Raises Cash and Some Concern - NYTimes.com
Subscribe to: Post Comments (Atom)
Post a Comment